Wed, Aug 20, 2014, 8:51 AM EDT - U.S. Markets open in 39 mins.


% | $
Quotes you view appear here for quick access.

AstraZeneca PLC Message Board

  • fishhead33_98 fishhead33_98 Aug 5, 2010 12:38 PM Flag

    any update with partner PTN ?

    Palatin Technologies has an exclusive global licensing and research collaboration agreement with AstraZeneca AB, a major international pharmaceutical and healthcare business, to discover, develop and commercialize compounds that target melanocortin-4 receptors for the treatment of obesity, diabetes and related metabolic syndrome.

    The collaboration, based on Palatin’s melanocortin-4 receptor program for the treatment of obesity, provides AstraZeneca access to compound libraries, core technologies and expertise in melanocortin receptor drug discovery and development.

    Palatin Technologies and AstraZeneca have made significant progress under the collaboration agreement, using core technologies in lead generation and expertise in melanocortin biology developed by Palatin Technologies. A near term objective of the collaboration with AstraZeneca is to advance a commercial drug candidate into clinical trials.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
70.52+0.81(+1.15%)Aug 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
JA Solar Holdings Co., Ltd.
NasdaqGSTue, Aug 19, 2014 4:00 PM EDT
TASER International Inc.
NasdaqGSTue, Aug 19, 2014 4:00 PM EDT